Deciphera Pharmaceuticals, Inc. Retained Earnings
Deciphera Pharmaceuticals, Inc. had Retained Earnings of -$1.47 billion as of 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2024-05-10
- 2024-03-31: Retained Earnings (Accumulated Deficit) -$1.47B.
- 2023-12-31: Retained Earnings (Accumulated Deficit) -$1.43B.
- 2023-09-30: Retained Earnings (Accumulated Deficit) -$1.38B.
- 2023-06-30: Retained Earnings (Accumulated Deficit) -$1.33B.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2024-03-31 | -$1.47B 10-Q · filed 2024-05-10 |
| 2023-12-31 | -$1.43B 10-Q · filed 2024-05-10 |
| 2023-09-30 | -$1.38B 10-Q · filed 2023-10-30 |
| 2023-06-30 | -$1.33B 10-Q · filed 2023-08-09 |
| 2023-03-31 | -$1.28B 10-Q · filed 2023-05-03 |
| 2022-12-31 | -$1.23B 10-K · filed 2024-02-07 |
| 2022-09-30 | -$1.19B 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$1.14B 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$1.10B 10-Q · filed 2022-05-04 |
| 2021-12-31 | -$1.05B 10-K · filed 2023-02-07 |
| 2021-09-30 | -$966.04M 10-Q · filed 2021-11-02 |
| 2021-06-30 | -$886.20M 10-Q · filed 2021-08-03 |
| 2021-03-31 | -$815.77M 10-Q · filed 2021-05-04 |
| 2020-12-31 | -$754.47M 10-K · filed 2022-02-08 |
| 2020-09-30 | -$691.73M 10-Q · filed 2020-11-05 |
| 2020-06-30 | -$628.03M 10-Q · filed 2020-08-04 |
| 2020-03-31 | -$560.79M 10-Q · filed 2020-05-05 |
| 2019-12-31 | -$487.98M 10-K · filed 2021-02-09 |
| 2019-09-30 | -$420.76M 10-Q · filed 2019-11-04 |
| 2019-06-30 | -$364.57M 10-Q · filed 2019-08-02 |
| 2019-03-31 | -$343.11M 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$295.72M 10-K · filed 2020-03-09 |
| 2018-09-30 | -$263.42M 10-Q · filed 2018-11-08 |
| 2018-06-30 | -$238.99M 10-Q · filed 2018-08-07 |
| 2018-03-31 | -$217.30M 10-Q · filed 2018-05-08 |
| 2017-12-31 | -$195.87M 10-K · filed 2019-03-14 |
| 2016-12-31 | -$145.59M 10-K · filed 2018-03-28 |